Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells. | Exp Ther Med | 2022 | 36340608 | PubTator, text mining | PubMed |
| Gut microbiota-dependent adaptor molecule recruits DNA methyltransferase to the TLR4 gene in colonic epithelial cells to suppress inflammatory reactions. | Front Mol Biosci | 2022 | 36339704 | PubTator, text mining | PubMed |
| PLK2 Single Nucleotide Variant in Gastric Cancer Patients Affects miR-23b-5p Binding. | J Gastric Cancer | 2022 | 36316110 | PubTator, text mining | PubMed |
| Identification of TIMP2 as a Prognostic Biomarker and Its Correlation with Tumor Immune Microenvironment: A Comprehensive Pan-Cancer Analysis. | J Oncol | 2022 | 36304987 | PubTator, text mining | PubMed |
| Chitosan degradation products promote healing of burn wounds of rat skin. | Front Bioeng Biotechnol | 2022 | 36304900 | PubTator, text mining | PubMed |
| Transcription factor gene Pea3 regulates erectile function during copulation in mice. | PLoS One | 2022 | 36301850 | PubTator, text mining | PubMed |
| Resistance to Trastuzumab. | Cancers (Basel) | 2022 | 36291900 | PubTator, text mining | PubMed |
| Portrait of Molecular Signaling and Putative Therapeutic Targets in Prostate Cancer with ETV4 Fusion. | Biomedicines | 2022 | 36289913 | PubTator, text mining | PubMed |
| Genetic Variants of CITED2 Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional Verification. | J Cardiovasc Dev Dis | 2022 | 36286273 | PubTator, text mining | PubMed |
| HIF-3α-Induced miR-630 Expression Promotes Cancer Hallmarks in Cervical Cancer Cells by Forming a Positive Feedback Loop. | J Immunol Res | 2022 | 36277475 | PubTator, text mining | PubMed |
| The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies. | Front Immunol | 2022 | 36275733 | PubTator, text mining | PubMed |
| pyDockDNA: A new web server for energy-based protein-DNA docking and scoring. | Front Mol Biosci | 2022 | 36275623 | PubTator, text mining | PubMed |
| Epigenetic impact of a 1-week intensive multimodal group program for adolescents with multiple adverse childhood experiences. | Sci Rep | 2022 | 36266402 | PubTator, text mining | PubMed |
| Identification of miRNA-mRNA-TFs regulatory network and crucial pathways involved in asthma through advanced systems biology approaches. | PLoS One | 2022 | 36264868 | PubTator, text mining | PubMed |
| Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability. | Oncogene | 2022 | 36253446 | PubTator, text mining | PubMed |
| A COP1-GATA2 axis suppresses AR signaling and prostate cancer. | Proc Natl Acad Sci U S A | 2022 | 36251994 | PubTator, text mining | PubMed |
| Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancer. | Noncoding RNA Res | 2022 | 36247409 | PubTator, text mining | PubMed |
| Novel POU3F4 variants identified in patients with inner ear malformations exhibit aberrant cellular distribution and lack of SLC6A20 transcriptional upregulation. | Front Mol Neurosci | 2022 | 36245926 | PubTator, text mining | PubMed |
| The Genomic Architecture of Pregnancy-Associated Plasticity in the Maternal Mouse Hippocampus. | eNeuro | 2022 | 36239981 | PubTator, text mining | PubMed |
| ALDH3A2, ODF2, QSOX2, and MicroRNA-503-5p Expression to Forecast Recurrence in TMPRSS2-ERG-Positive Prostate Cancer. | Int J Mol Sci | 2022 | 36232996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=23